MadScripts is now part of the Aphora Health family.
Member Support
arrow_forward

Grounded in real-world employer conversations, this article challenges the idea that rebate checks equal cost control. This piece explores why rebate season can create a false sense of progress, and what employers are doing to architect predictable costs, reduced total spend, and stability for members. If you’re guiding clients through pharmacy strategy, this article offers a practical lens on savings architecture, capture, and how to drive structural improvement without plan disruption.

Why A Big Rebate Check Isn’t the Same as Cost Control

Published:
April 1, 2026
Last Updated:
April 1, 2026
  • Rebate checks can create the illusion of progress, but they often reflect high list prices rather than true reductions in total pharmacy spend.
  • Employers are not looking for bigger rebate checks or more complexity; they want predictable costs, structural savings, and a stable member experience.
  • Aphora Health’s layered, transparent savings architecture increases spend capture across specialty, brand, and generics, driving measurable reductions in total pharmacy cost without disrupting the existing plan.

What Employers Are Actually Trying to Solve

I’ve been in enough pharmacy conversations with self-insured employers to notice something consistent.

When rebate season comes around, there’s often a sense of relief. The check shows up. The number may look substantial. It can feel like validation that the strategy is working.

But when we step back and look at total pharmacy spend, the picture is often very different.

A large rebate check usually reflects high list prices. It does not necessarily reflect lower net spend. In many cases, overall pharmacy costs continue to climb while the rebate check creates the appearance of improvement.

What Employers Are Actually Trying to Solve

Whether I’m speaking with a regional manufacturer with 250 employees or a national employer with 10,000+ lives, the underlying goals don’t change much.

They want predictable pharmacy costs. They want to reduce total spend, not just offset it. They want to avoid plan disruption. And they want their employees to have a smooth, excellent experience.

No one is asking for more complexity – what they are really asking for is control.

The Real Lever: Capture

In my view, pharmacy savings don’t improve meaningfully because pricing is marginally better. They improve when more of the employer’s pharmacy spend is routed through a structure that is transparent and not rebate-dependent.

That’s a capture issue, and that’s why we focus on savings architecture.

If specialty spend remains untouched, if brand leakage continues, if generics are not actively optimized, then the employer is only addressing the margins of the problem.

When you increase capture inside a transparent model, the savings move from incremental to structural.

We focus on resetting the baseline with savings architecture.  I’ll talk in more detail on the importance of capture in future articles.

This Isn’t About Blowing Up the Plan

One of the biggest misconceptions in pharmacy strategy is that meaningful savings require disruption.  They do not.

The model we’ve built at Aphora is intentionally layered. We work alongside existing PBM relationships. We don’t require plan redesign. We don’t introduce formulary chaos.

Instead, we redirect high-impact categories — specialty, brand, and generics — into transparent pricing while preserving stability for members.

Employees receive $0 copay access and the same manufacturer medications. Employers receive clear reporting and visible savings. Brokers maintain continuity in their broader benefit strategy.

The goal isn’t disruption. It’s controlled redirection.

This Applies at Every Scale

For smaller employers, a single specialty claimant can distort an entire year. Pharmacy volatility hits hard and fast.

For mid-sized employers, pharmacy trend often erodes operating margin quietly, forcing adjustments elsewhere in the benefits strategy.

For large national or international enterprises, the numbers are larger but the structural issue is the same. Opaque pricing and rebate dependency make long-term cost control difficult.

Different size but the same mechanics.

When pharmacy spend is captured inside a transparent structure, savings compound regardless of employer scale. The impact simply grows with the population.

The Question I Usually Ask

Instead of asking how large the rebate check was, I think a better question is: Has total pharmacy spend declined year over year?

If the answer is no, then the model probably hasn’t changed — only the optics have.

Pharmacy benefits are too material to be managed through annual reconciliation. They require structure. That’s the shift we focused on with our partners and customers.

If you are a self-insured employer or broker looking bring value without waiting for renewal season, you can learn more about implementing Aphora Health by clicking this link: https://aphorahealth.com/real-savings-0226-b1